Latest Breaking News On - Dishman carbogen amcis - Page 12 : comparemela.com

Dishman Carbogen Amcis reports consolidated net loss of Rs 135 02 crore in the March 2021 quarter

Dishman Carbogen Amcis reports consolidated net loss of Rs 135 02 crore in the March 2021 quarter
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Particularsquarter endedyear endedmarDishman carbogen amcisQuarter endedyearVar salesCapital marketIshman pharmaceuticals and chemicalsHarmaceuticals necDishman carbogenவார் விற்பனைமூலதனம் சந்தை

Linde India: Stocks in the news: GCPL, Linde India, HFCL, IOB, JMC Projects and IndiGo

Firstsource Solution, Granules India, Kalpataru Power, Neuland Labs, Alembic, Huhtamaki India and Dishman Carbogen Amcis are among companies that will announce their March quarter results today. HFCL: The domestic telecom gear maker posted a multifold jump in its consolidated net profit to Rs 86.47 crore in the quarter ended March 31, 2021. The company had posted a net profit of Rs 8.7 crore in the corresponding period of the previous year. Indian Overseas Bank: State-owned lender said its board will meet next week to issue preference shares to the government for Rs 4,100 crore capital infusion. A meeting of the board of directors for the issue of equity share capital would be held on Monday, May 17, 2021, to issue and allot shares to the government on a preferential basis for the capital infusion of Rs 4,100 crore,

India generalDishman carbogen amcisIndian overseas bankPunjab national bankSingapore exchangeDalal streetLinde indiaGranules indiaKalpataru powerNeuland labsHuhtamaki indiaOverseas bankGlobe aviationNational bankQualified institutional placementReserve bank

Nifty today: SGX Nifty down 200 points; here s what changed for market while you were sleeping

Domestic stocks looked set to see a gap-down start on Tuesday, following an overnight steep fall in US stocks amid fears of rising inflation in the world’s largest economy. Asian markets were all in deep red and technical charts for key domestic indices hinted at profit booking ahead. Here s breaking down the pre-market actions: STATE OF THE MARKETS Nifty futures on the Singapore Exchange traded 205 points, or 1.37 per cent, lower at 14,783.50, signalling that Dalal Street was headed for a gap-down start on Tuesday. Tech View: Nifty likely to see profit booking Nifty50 formed a bullish Doji kind of candle on Monday, indicating indecisiveness among investors. The trading range was narrower than the previous session, which is likely a hint of a slowdown in the upward journey as well as profit taking. Analysts advised traders to avoid Nifty trades for the time being, considering the narrow trading range, and shift focus to stock-specific opportunities.

United statesDishman carbogen amcisFitch ratingsAarti industriesNational bureau of statisticsIndia incFederal reserveSingapore exchangeDalal streetHang sengShanghai compositeDow jones industrial averageNeuland labsGodrej consumer productsLinde indiaFirstsource solution

SGX Nifty indicates 200 points decline for Nifty - The Hindu BusinessLine

SGX Nifty indicates 200 points decline for Nifty May 11, 2021 Four day rally may take a pause on weak global cues Indian markets are expected to open bearish on Thursday, amidst concern over Covid impact and weak global cues. The SGX Nifty, which currently rules at 14,783 (8 am IST) on the Singapore Stock Exchange, indicates at least 200 points gap-down opening for Nifty futures, which on Monday closed at 14,984.65 The US markets, after opening on a firm note on Monday failed to sustain the gains and closed in the red. The Dow Jones Industrial Average slipped marginally, while S&P 500 and Nasdaq crashed over 1 per cent and 2 per cent respectively. Tracking the US markets, the Japan’s Nikkei is down 2.5 per cent in early trade on Tuesday. Other markets such as Korea, Australia, Taiwan and China are down between 0.8 per cent and 1.5 per cent.

India generalAndhra pradeshMallikarjuna raoDishman carbogen amcisMotilal oswalAditya birla renewablesTranscorp internationalShreyans industriesPunjab national bankSangam renewablesStovec industriesWaacox energy privateWaaree renewables technologiesSingapore stock exchangeFirstsource solutionsModison metals

India s Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment

India s Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment India s Ab-drug-conjugate API manufacturer expands to Switzerland with CHF 15 M investment 29 April 2021 | News Dishman Carbogen Amcis announces that its subsidiary, Carbogen Amcis AG has entered into a co-investment agreement to create a state-of-the art facility to produce commercial antibody-drug-conjugate API Photo Credit: Dishman Carbogen Amcis The company’s subsidiary, Carbogen Amcis AG, pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced a joint funding agreement with a longstanding Japan-based customer to build a site extension at the Bubendorf site in Switzerland. The expansion will be created adjacent to an existing manufacturing facility on the Bubendorf Switzerland Site. This important expansion will incorporate a new production line comprising of two 850 L reactors and one agitated filt

Switzerland generalUnited kingdomMark griffithsDishman carbogen amcisPascal villemagneCarbogen amcisActive pharmaceutical ingredientsBubendorf switzerlandசுவிட்சர்லாந்து ஜநரல்ஒன்றுபட்டது கிஂக்டம்குறி கிரிஃபித்ஸ்செயலில் மருந்து பொருட்கள்